Gainers
CinCor Pharma, Inc. (NASDAQ: CINC) shares jumped 137% to $27.93 after AstraZeneca announced it will acquire the company for $26 per share in cash.
Apexigen, Inc. (NASDAQ: APGN) jumped 111% to $1.99 after climbing more than 10% on Friday.
Amryt Pharma plc (NASDAQ: AMYT) gained 106.7% to $14.49 after Chiesi Farmaceutici announced it will acquire the company for $14.50 per ADS plus contingent value rights of up to an additional $2.50 per ADS.
Albireo Pharma, Inc. (NASDAQ: ALBO) shares climbed 92.9% to $44.03 after Ipsen announced it will acquire the company for $42 per share plus a contingent value right of $10 per share.
Duck Creek Technologies, Inc. (NASDAQ: DCT) gained 47% to $19.10 after the company agreed to be acquired by Vista Equity Partners for $2.6 billion.
Revance Therapeutics, Inc. (NASDAQ: RVNC) surged 43% to $28.25 as the company reported the FDA acceptance Of supplemental Biologics License Application for DAXXIFY for injection for the treatment of cervical dystonia.
Novo Integrated Sciences, Inc. (NASDAQ: NVOS) rose 35.9% to $0.2052. Novo Integrated Sciences recently reported it entered an agreement to purchase 100% of shares of SWAG in exchange for $1.00.
Sema4 Holdings Corp. (NASDAQ: SMFR) gained 34% to $0.3299. Sema4 sees preliminary 2022 pro-forma revenues of $170 million to $173 million.
Comera Life Sciences Holdings, Inc. (NASDAQ: CMRA) gained 32% to $2.02. Comera Life Sciences 10% owner Charles Cherington bought a total of 743,243 shares at an average price of $1.23.
Party City Holdco Inc. (NYSE: PRTY) climbed 31.9% to $0.2363. Party City shares dropped 50% on Friday following a report suggesting the company has hired a restructuring advisor and plans a bankruptcy filing within weeks.
Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 30.9% to $1.7150. Bed Bath & Beyond shares dropped over 22% on Friday following a report indicating the company could file for bankruptcy in the coming weeks.
CureVac N.V. (NASDAQ: CVAC) shares rose 30.4% to $10.77. CureVac shares jumped over 29% on Friday after the company announced data on joint COVID-19 and flu mRNA vaccine development programs.
ZyVersa Therapeutics, Inc. (NASDAQ: ZVSA) jumped 28% to $2.06.
Better Choice Company Inc. (NYSE: BTTR) gained 28% to ...
Related tickers: FWBI, GROV, GHSI, CINC, GREE, BTTR, TMPO, NSTG, AMYT, ARWR, CMRA, MARA, LU, BBBY, GSUN, RVNC, BTBT, BCRX, MEGL, SNOW, CVAC, CERS, APGN, PRTY, HRMY, VYNE, COIN, HPCO, CALA, KRON, CUTR, PKBO, CRBP, PAYA, EXAS, ZVSA, LX, VIRX, NEPT, MLEC, CYAD, IFBD, DCT, HKD, BITF, M, ALBO, GLUE, TSLA, NVOS, SMFR, Z, RIOT, XOS, BRFH, ARVN.
Read Full Article
